Full Press Release Details
to Present at Three Upcoming Investor Conferences
Calif. and VANCOUVER, British Columbia, July 12, 2021- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) ("BriaCell"
or the "Company"), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast
cancer and other cancers, today announced that Dr. William V. Williams, President & CEO of BriaCell, is scheduled to present in the
following virtual conferences:
| Dr. Williams will be speaking at the conference at 2:30pm ET on July 14, 2021. | ||
| Management will be available for one-on-one meetings to be held throughout the conference. | ||
| The presentation will be webcast live and available for replay at Webcast URL . | ||
| For additional information on the conference, please visit: https://www.accesstogiving.com/ . |
| Dr. Williams will deliver his corporate presentation at 1:15pm ET on August 17, 2021. | ||
| Investors may request one-on-one meetings with Dr. Williams. | ||
| Investors may register for the conference here: https://investorsummitgroup.com/ . |
| Dr. Williams will deliver his corporate presentation at 10:30am ET on August 18, 2021. | ||
| Investors may request one-on-one meetings with Dr. Williams. | ||
| Investors may register for the conference here: https://conference.snn.network/ . |
BriaCell Therapeutics Corp.
is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer. More information
is available at https://briacell.com/.
press release contains "forward-looking statements" that are subject to substantial risks and uncertainties. All statements,
other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements
contained in this press release may be identified by the use of words such as "anticipate," "believe," "contemplate,"
"could," "estimate," "expect," "intend," "seek," "may," "might,"
"plan," "potential," "predict," "project," "target," "aim," "should,"
"will" "would," or the negative of these words or other similar expressions, although not all forward-looking
statements contain these words. Forward-looking statements are based on BriaCell's current expectations and are subject to inherent
uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions
as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully under the heading
"Risks and Uncertainties" in the Company's most recent Management's Discussion and Analysis, under "Risks
and Uncertainties" in the Company's other filings with the Canadian securities regulatory authorities and the U.S. Securities
and Exchange Commission, all of which are available under our profiles on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
Forward-looking statements contained in this announcement are made as of this date, and BriaCell Therapeutics Corp. undertakes no duty
to update such information except as required under applicable law.
TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.